Life Expectancy Gains Are Stalling and Longevity Science Needs a New Playbook

For most of the 20th century, life expectancy in wealthy nations climbed at a remarkable pace, driven largely by reductions in infant and child mortality, better sanitation, and the advent of antibiotics. That era of rapid gains now appears to be over. A new study published in the Proceedings of the National Academy of Sciences examined life expectancy trends across 23 high-income countries and found that progress has slowed to a trickle — roughly 2.5 to 3.5 months of additional lifespan per generation for cohorts born after 1939. The researchers project that people born in 1980 will not, on average, reach 100 years of age.

The core explanation is structural: the interventions that produced the largest historical gains — reducing deaths in infancy and early childhood — have already been largely achieved in high-income settings. What remains is the harder problem of compressing morbidity and extending healthy years in older adults, a challenge that current medicine has not yet solved at scale.

This finding lands at a moment when the longevity research community is undergoing its own reckoning. At the International Conference on Targeting Longevity 2026 in Berlin, leading researchers argued that the field must move beyond single-target molecular therapies toward coordinated modulation of interconnected biological systems. Dr. Marvin Edeas captured the tension: extraordinary discoveries have been made, yet clinical implementation remains fragmented and piecemeal.

The proposed reframe treats aging not as a collection of isolated defects but as a systems-level failure of resilience — involving mitochondrial function, immune regulation, the gut microbiome, and metabolic signaling simultaneously. Future interventions may need to stabilize these networks collectively rather than targeting one pathway at a time.

The longevity market is projected to reach $67 billion by 2035, signaling enormous commercial momentum. Whether that investment translates into genuine healthspan extension will depend on whether the science can match the ambition.